49 results on '"Gioulbasanis, Ioannis"'
Search Results
2. An international study of clinical, demographic and competence-related determinants of communication with professionals
3. An international field study for the reliability and validity of the EORTC Communication Questionnaire EORTC QLQ-COMU26
4. Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
5. A genome wide association study to identify germline copy number variants associated with cancer cachexia: a preliminary analysis.
6. A genome wide association study to identify germline variants associated with cancer-associated cachexia - a preliminary analysis
7. Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
8. Objective Measurements of Physical Function to Predict Survival in Patients with Metastatic Cancer
9. Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies
10. Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire
11. New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
12. Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
13. Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi‐cohort analysis
14. Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study
15. Cancer-associated anorexia: Validity and performance overtime of different appetite tools among patients at their first cancer diagnosis
16. Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis
17. Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer
18. Cancer patient satisfaction with health care professional communication: An international EORTC study.
19. Assessment of nutritional status
20. Selecting for predisposition to cancer cachexia
21. Beyond anorexia -cachexia. Nutrition and modulation of cancer patientsʼ metabolism: Supplementary, complementary or alternative anti-neoplastic therapy?
22. Cancer cachexia syndrome in the prediction of outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a single-institution, prospective, observational study.
23. Body composition in patients with non--small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
24. Cancer cachexia, sarcopenia and hand-GRIP strength (HGS) in the prediction of outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): A prospective, observational study.
25. Cancer‐Associated Malnutrition and CT‐Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients
26. Corrigendum to 'Prognosis in advanced lung cancer - a prospective study examining key clinicopathological factors' [Lung Cancer 88 (2015) 304-309]
27. Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients.
28. Nutritional status and objective assessment of functional status in patients with neoplastic diseases receiving antineoplastic therapy: Preliminary results
29. New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
30. Detailed Dietary Assessment in Patients with Inoperable Tumors: Potential Deficits for Nutrition Care Plans
31. New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
32. The impact of chronic pain in nutritional status and prognosis of patients with metastatic cancer primaries
33. The effect of isotonic drinks on electrolyte abnormalities of ileostomy patients: Preliminary results
34. Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors
35. Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss
36. 17
37. The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer
38. Prognostication in non-small cell lung cancer.
39. Selectin g for predisposition to cancer cachexia
40. Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer
41. Baseline Plasma Levels of Interleukin-8 in Stage IV Non-Small-Cell Lung Cancer Patients: Relationship With Nutritional Status and Prognosis
42. Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: Interrelations and associations with prognosis
43. Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis
44. Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer
45. Non-Platinum-Based First-Line Followed by Platinum-Based Second-Line Chemotherapy or the Reverse Sequence in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis by the Lung Cancer Group of the Hellenic Oncology Research Group
46. Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancer
47. A Dose Escalation Study of the Biweekly Administration of Paclitaxel, Oxaliplatin and Capecitabine in Patients with Advanced Solid Tumors
48. Corrigendum to "Prognosis in advanced lung cancer - A prospective study examining key clinicopathological factors" [Lung Cancer 88 (2015) 304-309].
49. Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.